Literature DB >> 30239700

Towards biobased industry: acetate as a promising feedstock to enhance the potential of microbial cell factories.

Katharina Novak1, Stefan Pflügl1.   

Abstract

A broad range of different chemical and pharmaceutical compounds have been produced in microbial cell factories. To compete with traditional crude oil based production processes, the use of complex alternative raw materials such as lignocellulosic biomass, waste streams and utilization of CO2 in gas fermentations has been suggested. All of these streams contain acetate, a cheap and potentially interesting carbon source for microbial production processes. Acetate (co-)utilization remains challenging, which is the reason for extensive research on the use of acetate for the production of value-added compounds. For industrial implementation of microbial conversion processes using acetate as a feedstock gaining a deeper insight into acetate metabolism of microorganisms is essential. Systems level analyses and manipulation of potential host organisms should be applied to achieve full utilization of this prospective substrate.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30239700     DOI: 10.1093/femsle/fny226

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

Review 1.  The Potential of Sequential Fermentations in Converting C1 Substrates to Higher-Value Products.

Authors:  Christina Stark; Sini Münßinger; Frank Rosenau; Bernhard J Eikmanns; Andreas Schwentner
Journal:  Front Microbiol       Date:  2022-06-03       Impact factor: 6.064

2.  Microbial upgrading of acetate into 2,3-butanediol and acetoin by E. coli W.

Authors:  Katharina Novak; Regina Kutscha; Stefan Pflügl
Journal:  Biotechnol Biofuels       Date:  2020-10-22       Impact factor: 6.040

Review 3.  Microbial Upgrading of Acetate into Value-Added Products-Examining Microbial Diversity, Bioenergetic Constraints and Metabolic Engineering Approaches.

Authors:  Regina Kutscha; Stefan Pflügl
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.